Who benefits when the marketplace changes its price?

To a patient, Zocdoc can look like a straightforward way to find a clinician and reserve an appointment. To a practice, it is also a way to acquire patients and fill capacity. Those are connected services, but they are not identical. The patient wants a suitable appointment, with the right insurance and timing. The practice wants worthwhile demand without an unpredictable acquisition cost. The platform has to persuade both sides to participate while collecting revenue primarily from one of them.

In a 2019 letter, founder and CEO Oliver Kharraz explained a shift from a flat subscription toward charging providers for each new patient booking. He said the former arrangement prevented some providers from joining and that the change would broaden patient choice. The New York transition was scheduled to start that April. This is primary evidence of the company's rationale, not proof that every practice would benefit. The important decision was to change the economic unit from access to the platform to an action generated by it.

That change redistributed risk. A practice expecting few bookings could face a lower barrier to trying the service. A practice receiving many bookings could face a larger bill. The same price structure could therefore improve participation at one end of the market and provoke resistance at another. It also raised a more precise question about value: was the platform delivering a booking, an attended visit, a suitable patient, or a continuing clinical relationship? Those outcomes are related, but their economics differ.

Fierce Healthcare reported criticism from New York doctors in August 2019, alongside the company's defense of the change. Its account described an annual licensing fee and additional charges for new patient bookings, replacing the previous flat subscription. The objections are useful evidence of stakeholder tension, not a representative survey of every provider. A founder should take neither the company's growth argument nor a dissatisfied customer's account as the complete market. Each reveals a different part of the bargain that needs to be tested.

The company later described the transition in a turnaround account, attributing improved business performance to the pricing change. That remains a management interpretation. Pricing, product, demand, sales execution, and market conditions can move together. The case does not establish that a single change caused the outcome. It does show that a marketplace cannot treat monetization as a neutral layer added after product-market fit. How it charges influences who joins, how actively they participate, and what they expect the platform to deliver.

There is also a patient consequence. More participating practices may expand choice, but the relevant measure is usable access: appointments that are available, appropriate, and consistent with the patient's coverage. A directory can grow without improving that result. Conversely, a smaller set of reliable appointments can be more valuable than a large but misleading inventory. These are analytical tests for the marketplace, not claims about Zocdoc's performance. They require looking beyond registrations and bookings to the completion and suitability of the underlying care encounter.

Examine the same pricing decision from three positions and a different marketplace comes into view. Ask a new practice what makes participation affordable. Ask an established practice what outcome justifies the charge. Ask a patient what makes a booking trustworthy. Then choose a payment unit that the platform can explain and measure honestly. Zocdoc's pricing episode is a useful reminder that value is not one shared number. An effective marketplace has to make several different calculations compatible enough for the relationship to continue.

For a discussion tailored to your team, explore a workshop with Julien.